World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172 countries and territories. Its mission is to reduce the global cancer burden, promote equity and awareness, ensuring that cancer control continues to be a priority in the world health and development agenda. 

More than half of oncologic patients receive radiation therapy as part of their treatment. Intelligent and comprehensive solutions offered by MVision AI actively support radiation oncology professionals to increase their productivity and improve their knowledge, in the best interest of cancer patients.

According to the World Health Organization, cancer is diagnosed in 18 million people every year, globally, and the numbers are expected to double by 2050. 

Extensive efforts are made to treat it in the best possible way and offer patients a chance to cure or extend their life for many years from diagnosis. Another important aim in oncology is to preserve and improve their quality of life, regardless of the stage of the disease.

Treating cancer implies joint actions of patients, their caregivers and health professionals. Unfortunately, access to adequate healthcare is not always available. Comprehensive treatments are available in 90% of the high-income countries but only 15% from low-income countries.  Closing the care gap is one of the main priorities of international societies and public health structures.

Substantial budget, but also a high level of education and intelligent solutions are needed to improve cancer care. Delivering quality radiation therapy in a timely manner is hampered by insufficient infrastructure or staff shortage. Implementing artificial intelligence in Radiation Oncology already demonstrated promising results for improving the complex process of treatment preparation and delivery.

MVision AI offers intelligent and comprehensive solutions for a fast, precise and standardized treatment. Improved efficiency allows professionals to better use their time, for example interacting more time with patients or improving their skills. It also is beneficial from the logistic perspective, enabling the clinics to treat a higher number of patients, if needed, and lowering the waiting times. Such upgrades are increasingly used in clinical practice, and probably will become part of the gold standard in the next future.


  1. World cancer day.
  2. UICC.
  3. WHO. Cancer.
  4. Worldwide cancer data.,and%208.8%20million%20in%20women.
  5. Abdel-Wahab M, Gondhowiardjo SS, Rosa AA, et al. Global Radiotherapy: Current Status and Future Directions-White Paper. JCO Glob Oncol. 2021;7:827-842. doi:10.1200/GO.21.00029

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts


How can AI-based auto-contouring improve the life of patients who need palliative radiation therapy?

Cancer is one of the leading causes of morbidity and death, worldwide. Approximately 18 million people are diagnosed with cancer each year and the number is expected to increase. Pain is experienced by two thirds of patients having advanced, metastatic or terminal disease (1). Other symptoms caused by compression on…



MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland - January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL)…

Press Releases


The world’s first comprehensive GBS™ solution for radiation therapy cancer treatment is now available for implementation in Canadian clinics

HELSINKI, Finland - January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+).  In conjunction with Guide and Verify, Contour+ stands as a unique solution covering all the essential needs of radiotherapy departments, offering a more comprehensive approach to staff training and patient…

Press Releases